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Purpose: Poor health outcomes for patients living in rural and remote areas of Australia are 
often attributed to the lack of a range of accessible health professionals delivering health 
services. Community pharmacists are already an integral part of these communities and as 
such are often the most frequently consulted health professionals. The aim of this study was 
to explore rural pharmacist knowledge and experiences of expanded pharmacy and to 
identify the barriers and enablers to remote pharmacists providing expanded pharmacy 
services (EPS), which can be described as services outside of usual medication management 
tasks.
Methods: Rural and remote pharmacists (Modified Monash Model (MMM) categories 2–7) 
participated in an online survey. Descriptive statistics and chi-squared tests were performed 
and data from open-ended questions were analyzed, categorized into themes and quantitized.
Results: Two-thirds (n=13, 68%) of rural pharmacists surveyed (n=19) had knowledge of 
EPS in rural pharmacies and the majority (n=17, 89%) agreed that these services would 
benefit rural communities. Mental health service referral was considered very/extremely 
important by the majority (n=16, 84%) of respondents; however, no pharmacists were 
currently providing mental health screening services while (n=15, 79%) were willing to 
provide these services. While staff shortages, costs, time and training were indicated to be the 
main barriers to the provision of EPS, enablers included accessibility of rural pharmacies and 
a perceived need.
Conclusion: This study indicated that pharmacists are already providing some EPS and see 
value in their implementation; however, what constitutes an expanded service was unclear to 
some participants. Mental health services were highlighted as most important demonstrating 
a recognized burden of mental illness in rural and remote locations. Findings from this pilot 
study will provide further understanding for future development of the pharmacist’s scope of 
practice and implementation of EPS.
Keywords: pharmacy, workforce, rural and remote, health outcomes, expanded scope
Introduction
In Australia, one-third of the country’s population is currently living in either 
regional, rural or remote locations, equating to approximately seven million 
people.1 Australians living in rural and remote regions of the country experience 
higher mortality rates and poorer health outcomes than their metropolitan 
counterparts.1 These poorer health outcomes can be attributed to the distances 
that people are required to travel to access health services, which is related to 
a lack of availability of health services in their local regions, mainly due to 
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a maldistribution of the health workforce.1–3 Difficulty of 
delivering health services is compounded by the lack of 
a range of health professionals, including doctors.4 In 
addition, these communities are small and highly dis-
persed, causing low population densities and long dis-
tances between rural towns.4 This presents a challenge 
when planning health service delivery for rural and remote 
locations.
Rural community pharmacists, accessible to rural and 
remote population groups, are frequently consulted by 
patients,5 and provide services to those who might not 
otherwise have contact with other health professionals.6 
Pharmacists are well recognized by patients and other 
health professionals for their role in medication manage-
ment, which is associated with supply of medicines.5 
Expanded pharmacy services (EPS) have been defined as 
pharmacists working to their “full” or “enhanced” scope of 
practice, involving the performing of activities usually 
provided by other health professionals.7,8 These services 
are described using various terminology in different parts 
of the world with terms such as “cognitive pharmaceutical 
services“, “minor ailment services“, and “professional 
pharmacy services“ being utilized.9–11 However, patients 
often only recognize the traditional supply function of the 
pharmacist, which involves dispensing prescription medi-
cines, providing over the counter medicines, advice and 
counselling.12 Recently, the pharmacist’s role has 
expanded to a “full scope of practice” to include public 
health services such as risk reduction of cardiovascular 
disease, osteoporosis screening, oral health care and 
immunization.12 However, in addition to patients lacking 
awareness of available services, pharmacists have also 
expressed concern about a lack of time, space and remu-
neration for the delivery of these services.13,14
Pharmacists’ opinions are that expanded practice 
would benefit the profession and their individual practice. 
This is aligned with the opinions of their customers, who 
perceived there to be barriers to expanded practice.13,14 
Pharmacists appear also to have not taken opportunities to 
work to their “full scope of practice” and some seem 
confused as to what constitutes expanded practice.15 To 
bring about change is complex, with nine themes relevant 
to practice change being identified in a study based in 
Ontario, Canada.15 These included regulation associated 
with the expanded scope of practice, which involves 
changes to legalization and procedural guidance to trans-
late EPS into day-to-day activities.15 Pharmacists also 
required practice to ensure confidence in the new activity, 
positive reinforcement and personalized attention rather 
than group-based education to support implementation of 
EPS.15 Due to the often solitary nature of pharmacy prac-
tice, particularly in rural areas, peer referencing to shape 
attitudes and redirect practices in addition to physician 
acceptance was also considered essential for EPS imple-
mentation. Patient expectations and professional identity 
were reported as both barriers and enablers toward chan-
ging practice.15
Pharmacists’ attitudes and attributes have been 
described by Luetsch16 as barriers and facilitators to the 
uptake of expanded practice. Some pharmacists appear to 
be hesitant to provide EPS, due to lack of evidence that 
these services will be beneficial to the patients.16 Although 
pharmacists often expressed positive attitudes, implemen-
tation and provision of these services was often lacking.16 
Furthermore, literature regarding EPS in a rural and 
remote Australian context, where there is restricted access 
to other health providers including GPs, allied health 
practitioners, and specialist services, is limited. For this 
reason, and the potential contribution EPS could make to 
health outcomes for rural populations, the purpose of this 
study was to explore the knowledge, attitudes and prac-
tices of pharmacists towards EPS in rural and remote 
Australia, and to identify the perceived barriers and 
enablers to the delivery of these services.
Methods
A cross-sectional pilot study was conducted, which 
included the design of a survey of EPS in rural and remote 
Australia to explore the knowledge, attitudes and prac-
tices of rural pharmacists towards EPS, and their per-
ceived barriers and enablers to delivery of these 
services. The survey and EPS listed therein was informed 
by a review of the literature examining EPS provided in 
rural locations globally. The survey was piloted with four 
rural pharmacists who were excluded from the results, 
minor changes were incorporated in the final survey. 
The survey was divided into four sections with a total of 
23 questions, including knowledge of expanded services, 
attitudes and practices towards these services, barriers and 
enablers and demographic information. The survey 
included five-point Likert scale and open- and closed- 
ended questions. Participants received no incentives for 
participating in the survey, which took approximately 20 
min to complete. Data were collected during April and 
May, 2019.
submit your manuscript | www.dovepress.com                                                                                                                                                                                                                    
DovePress                                                                                                                                       
Journal of Multidisciplinary Healthcare 2020:13 1782






































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
The survey was delivered online via Survey Monkey 
and distributed via email through various rural pharmacy 
networks including the Pharmaceutical Society of 
Australia, Society of Hospital Pharmacists of Australia, 
Services for Australian Rural and Remote Allied Health, 
Rural Pharmacy Support Network, and the James Cook 
University School of Pharmacy Alumni. The participants 
were required to be practicing in Modified Monash 
Model17 (MMM) category 2–7 locations. The MMM clas-
sifies areas of Australia according to level of geographical 
remoteness and population size, where MM1 is “metropo-
litan“, while MM7 is “very remote.”17
Data Analysis
Descriptive statistical analysis was undertaken to interpret, 
categorize, and describe the quantitative data. Data from 
open-ended questions were analyzed with meaningful 
statements categorized into themes and quantitized. Chi- 
squared tests using IBM SPSS Statistics for Windows, 
version 25.0. released 2017 (IBM Corporation, Armonk, 
NY, USA) were conducted to find out if there was 
a relationship between importance of listed EPS, MMM 
category, and length of time employed in rural pharmacy.
Research Ethics
James Cook University Human Research Ethics 
Committee granted ethical approval H7752. Information 
regarding the study and its objectives was provided before 




A total of 19 pharmacists completed the survey. 
Demographic data are presented in Table 1. Just over two- 
thirds of participants were female and 37% were aged 
26–35 years. Respondents were evenly distributed over 
all nonmetropolitan MMM categories (MM2-7), and 58% 
had over 10 years of pharmacy experience.
Knowledge of and Attitudes Towards EPS
The survey included questions designed to explore phar-
macists’ knowledge of and attitudes towards EPS (see 
Table 2). While most participants (68%) agreed that EPS 
were currently being provided in rural pharmacies in 
Australia, only 58% agreed that they provide these ser-
vices at their current place of employment. Respondents 
seem to view EPS positively, as the majority agreed that 
rural pharmacies are well placed to provide EPS (84%), 
and that these services would benefit those living in rural 
communities (89%). Almost two-thirds also agreed that 
EPS would be a motivating factor in attracting pharmacists 
to work in rural communities.
Participants’ attitudes were also gauged by asking them 
to apply a rank of importance from one (not important) to 
five (extremely important) to 36 EPS. These EPS com-
prised of basic examination, assessment or screening; 
treatment; referral; and supply of relevant products and 
education for a range of acute and chronic conditions 
including speech and swallowing, mental health, respira-
tory health, osteoporosis, musculoskeletal conditions, oral 
health, ocular health, hearing, diabetic foot screening and 
podiatry, acute infections, and drug and alcohol services. 
Table 3 displays the 10 most and least important EPS as 
selected by the rural pharmacist participants. “Most impor-
tant” EPS was determined by most frequent selection of 

















Employed pharmacist 6 (32)
Pharmacy manager 2 (11)
Owner/partner 5 (26)
Academic 1 (5)
Not specified 5 (26)
Years in rural pharmacy
<1 year 0 (0)
1–3 years 5 (26)
4–6 years 2 (11)
7–10 years 1 (5)
10+ 11 (58)
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very/extremely important, whilst “least important” was 
determined by most frequent selection of “not important”, 
and then by least frequent selection of “very/extremely 
important”.
Half of the most important EPS chosen were referral 
services and referral to available, appropriate mental 
health services was considered very/extremely important 
by 84% of respondents. The remaining most important 
EPS were for examination and treatment of acute condi-
tions such as communicable diseases or mental health 
issues. EPS considered to be least important by respon-
dents were assessment, examination, or screening services 
(70%). Speech and language assessments, heel scans, and 
hearing testing were most often selected to be “not impor-
tant” to rural pharmacy practice, by the participants. 
Speech and swallowing, hearing, and substance-abuse 
related services all appeared more than once in the least 
important services table.
Participants were given the opportunity to list 
expanded services that they were already providing. The 
most common services included six pharmacists providing 
vaccinations, three providing home medicine reviews, 
three offering blood pressure monitoring, three preparing 
dose administration aids, and two offering sleep apnea 
services. Asthma management, COPD screening, CVD 
screening, blood sugar screening, weight management, 
and smoking cessation services were each listed once. 
Three participants’ inclusion of “dose administration 
aids” as an expanded service they provide at their phar-
macy may indicate a possible misunderstanding among 
pharmacists of what defines an EPS.
Practices Involving EPS
Participants responded whether their pharmacy currently 
provides, or if they would be interested in providing each 
service (see Table 4). Of the ten most important services 
listed in Table 3, all were currently being provided in two 
(11%) participants’ place of work, with the exception of 
“conduct basic mental health assessments using screening 
tools.” The participant group consistently stated (100% of 
10 most important EPS) that they would like to deliver 
these services as often or more often than current practice.
The importance attached to mental health service 
provision in rural and remote areas was clearly demon-
strated. Although “conduct basic mental health assess-
ments using screening tools” was not a current service at 
any of the participants’ workplaces, 79% responded that 
they would like to provide this service. Similarly, only 





EPS are provided in rural pharmacies 13 (68) 6 (32)
EPS are provided in your pharmacy 58 (58) 8 (42)
Rural pharmacies are well placed to 
provide EPS
16 (84) 3 (16)
EPS would benefit people in rural 
communities
17 (89) 2 (11)
EPS would attract pharmacists to rural 
communities
12 (63) 7 (37)
Table 3 Ten Most/Least Important EPS to Rural Pharmacy 
Practice as Selected by Rural Pharmacists
10 Most Important EPS n (%) Type of 
Service
Refer patients to available and appropriate 
mental health services
16 (84) R
Refer patients to infectious disease services, 
eg GP, sexual health clinic
13 (68) R
Refer patients to specialist drug services 13 (68) R
Refer patients to specialist respiratory 
services
12 (63) R
Refer patients to oral health services 12 (63) R
Conduct examinations for acute ocular 
conditions, eg conjunctivitis
15 (79) E
Assessing a patient’s suicide risk 14 (74) E
Conducting basic mental health assessments 
using screening tools
12 (63) E
Provide treatment for acute ocular 
conditions, eg conjunctivitis
14 (74) T
Provide treatment for acute feet conditions, 
eg Tinea pedis
13 (68) T
10 Least Important EPS
Refer patients to specialist ear/hearing 
services
3 (16) R
Conduct basic speech and language 
assessments
6 (32) E
Conduct heel scans in pharmacy 6 (32) E
Conduct basic hearing testing/screening 6 (26) E
Provide basic oral examinations 4 (21) E
Provide basic visual acuity assessments/ 
screening
4 (21) E
Conduct basic alcohol and drug usage 
examinations
3 (16) E
Conduct basic swallowing assessments 2 (11) E
Provide treatment for drugs of abuse 4 (21) T
Provide treatment for acute infections 3 (16) T
Abbreviations: R, referral; E, examination, assessment or screening; T, treatment.
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two (11%) participants reported that they currently pro-
vide patient suicide risk assessments, however 74% 
would like to provide them. Referral to mental health 
services, the EPS that was considered “most important” 
in Table 3 was already being provided by approximately 
half of the pharmacists (n=10, 53%), while an additional 
four respondents stated that they would like to provide 
this service in their rural pharmacy. The “most impor-
tant” examination and treatment of acute ocular and foot 
conditions services were already being provided by most 
respondents (all over 50%).
Barriers, Enablers and Expected 
Outcomes of Expanded Practice
Responses from open-ended question regarding the bar-
riers, enablers, and expected outcomes of expanded phar-
macy practice in rural and remote locations were analyzed 
and common or relevant statements and their frequency 
were identified and are presented in Table 5. Pharmacists 
perceived many more barriers than enablers to the provi-
sion of EPS. The most often stated barriers were regarding 
staff shortages, remuneration, training, and time. Enabling 
factors included a need for services, due to a lack of health 
providers in their area, and that rural pharmacies are well 
placed to provide EPS. They also believed that the intro-
duction of EPS would be enabled by their existing rapport 
and frequent contact with patients. Expected outcomes of 
the introduction of EPS in their pharmacy were consis-
tently positive, particularly regarding improved health 
outcomes for rural populations, benefits for health ser-
vices, and improved community relationships.
There was no statistically significant association 
between rurality or time spent working in rural areas and 
EPS (p>0.05). The lack of statistical significance between 
importance of EPS listed in this study, MMM category, 
and length of time employed in rural pharmacy may imply 
that all participants recognize that the EPS and associated 
health issues listed in the survey have some importance to 
their community. All health issues were generally consid-
ered to be “important” by respondents, regardless of these 
variables.
Discussion
While over two-thirds of pharmacists claimed knowledge 
that EPS were being delivered in community pharmacy, 
there appears to be some confusion as to which services 
constitute expanded practice, with blood pressure monitor-
ing, provision of dose administration aids, blood sugar 
screening, weight management, and smoking cessation 
being listed as expanded services. Although expanded 
practice has been described as a distinct knowledge and 
skill base that is in addition to the recognized scope of the 
pharmacy profession,8 pharmacists might see any service 
other than the traditional supply of medicines as expanded 
practice.12 This demonstrates an urgent need for the phar-
macy profession to develop clarity for pharmacists about 
what is defined as an expanded service. Attitudes to the 
provision of EPS are largely positive especially in relation 
Table 4 EPS Currently Being Provided/Would Like to Provide in Rural Pharmacies (10 Most Important EPS)
10 Most Important EPS Service Currently Provided 
n (%) Yes
Would Like to Provide Service 
n (%) Yes
± %
Conducting basic mental health assessments using 
screening tools
0 (0) 15 (79) +79%
Assessing a patient’s suicide risk 2 (11) 14 (74) +63%
Refer patients to specialist respiratory services 3 (16) 10 (53) +37%
Refer patients to infectious disease services, eg GP, sexual 
health clinic
8 (42) 13 (68) +26%
Refer patients to specialist drug services 6 (32) 11 (58) +26%
Refer patients to available and appropriate mental health 
services
10 (53) 14 (74) +21%
Conduct examinations for acute ocular conditions, eg 
conjunctivitis
13 (68) 14 (74) +6%
Refer patients to oral health services 13 (68) 14 (74) +5%
Provide treatment for acute ocular conditions, eg 
conjunctivitis
11 (58) 12 (63) +5%
Provide treatment for acute feet conditions, eg tinea pedis 16 (84) 16 (84) +0%
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to the accessibility of rural community pharmacists, as 
highlighted by Gregory et al15 and Luetsch16 however, 
the change in practice is complex and often reliant on 
acceptance by not only pharmacists and patients, but also 
other health professionals.
Respondents’ consistent high ranking of EPS related to 
mental health including referral to mental health services, 
conducting suicide risk assessments, and the use of basic 
mental health screening tools are expected considering the 
frequency and impact of poor mental health in rural and 
remote regions of Australia.18 There is evidence that an 
increased role of pharmacists in the treatment and manage-
ment of mental health has had a positive influence on both 
patient and pharmacist.19,20 A Canadian study found that 
pharmacists perceived the provision of support to patients 
with mental health and addictions improved pharmacist– 
patient relationships through increased rapport and trust.19 
Pharmacists also noticed a change in their own perceptions 
of stigma regarding mental illness, and benefited from 
increased collaboration with health professionals and com-
munity organizations.19 An Australian study found that 
mental health consumers and carers expected pharmacists 
to provide services beyond medication dispensing, includ-
ing individualized counselling, explanation of medication 
side-effects or medication information, communication 
between pharmacists and doctor to avoid potential drug 
interactions, patient education and information about rele-
vant community support services.20
Four of the “most important” EPS were services related 
to infectious diseases including minor ocular and sexually 
transmitted diseases. A consultation service for ear, nose, 
and throat and eye conditions was introduced in the UK, 
where pharmacists received training for patient examina-
tion and treatment of these conditions. Patients received 
appropriate diagnosis or treatment including prescription- 
only or over-the-counter medicine, advice, or referral to 
a GP.21 Most patients (85%) did not require treatment from 
another health professional after receiving treatment or 
advice from the pharmacist.21 Ninety-seven percent of 
patients who participated agreed that pharmacies were 
appropriate to provide the expanded service, and reasons 
for utilizing the pharmacist-provided consultation service 
included no need to make or wait for an appointment and 
convenience of pharmacy location or opening times.21
Five of the 10 “most important” EPS as perceived by 
respondents were referral services, which may imply that 
pharmacists recognize that they are well positioned to 
connect patients with appropriate health services via 
a formalized referral pathway. Pharmacist referrals to 
GPs and other health professionals have been documented 
in the literature and are generally described as appropriate 
and resulting in positive patient health outcomes.22 A UK- 
based study found that pharmacists referred patients to 
their GP within the first two weeks of taking antihyperten-
sive medication, with most common reasons for referral 
being experience of side-effects, not using the medication 
as prescribed, or negative feelings towards the medication 
or condition. The pharmacist referred 4.5% of patients 
back to their GP, while the other 95.5% were supported 
by the pharmacist without the need for referral.23 Another 
study concerning the GP-pharmacist relationship found 
Table 5 Pharmacist Statements (and Their Frequency) Regarding 
Barriers, Enablers, and Expected Outcomes of Expanded 
Pharmacy Practice
Barriers
Staff shortages, sole pharmacist retention, and recruitment of staff (14) 
Cost of providing services, lack of funding (8) 
Training and ongoing professional development required, cost of training, 
travel, locums (8) 
Time (5) 
Space/rooms required, patient privacy (3) 
Existing interprofessional relationships (2) 
Lack of services to refer to (2) 
Duplication of services already provided (1) 
Limited clients available due to small populations (1) 
There are not any enablers present (1) 
Would require formal training and introduction of “pharmacist 
practitioner” role similar to a nurse practitioner (1)
Enablers
Lack of other health service providers in rural areas, need for services (7) 
Pharmacies well situated in rural areas, accessible (6) 
Good rapport with patients, trust (3) 
Frequent contact with patient (2) 
Pharmacists are willing to expand services (1) 
Services that only take a short time (foot and ear checks) would be easy 
to implement (1) 
Pharmacists are capable of learning new skills and procedures (1)
Expected outcomes
Improved health outcomes for their community, indigenous health 
outcomes, mental health outcomes (12) 
Less burden on GPs/clinics, more collaborative care (4) 
Increased screening, specialist referral (4) 
Reduce travel for patients, making health care more accessible (4) 
Improved relationships with community (2) 
Financial benefits for government (2) 
Ensure viability of pharmacies in rural areas (1)
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that while GP-pharmacist interactions can be limited and 
are often tense, some pharmacists felt they had doctor’s 
respect in regard to contact regarding patient conditions, 
medication, and referrals.24 Pharmacists perceived that 
their actions and decisions assisted with the GP’s heavy 
workloads, only referring serious conditions to the GP, 
while the pharmacist could manage and treat minor 
issues.24 A New Zealand-based pharmacy asthma manage-
ment program, which aimed to resolve issues of medica-
tion/dose, administration, compliance, drug reactions and 
other related issues resulted in nearly half (49%) of 
patients being referred to a GP, respiratory specialist or 
asthma educator.25 However, while pharmacist referral to 
GP or other health providers is documented in the litera-
ture, sometimes no official referral procedure exists. For 
example, Hoang et al26 found that although rural 
Australian pharmacists provide oral health advice regu-
larly, there is no referral pathway from pharmacy to oral 
health services, and pharmacists had limited or no com-
munication with local dental services. This highlights 
a need for an explicit referral pathway and increased 
collaboration between pharmacists and other health ser-
vices, which have the potential to benefit pharmacists, 
health providers and patients.24,26,27
Community pharmacies are often the first contact for 
patients for minor conditions, are widely available, have 
longer hours of operation compared to GP clinics, and do 
not require an appointment for consultation.22,28 
Pharmacists are ideally placed to engage and educate 
patients, and are one of the most accessible and trusted 
health professionals.28 A review of literature regarding 
community pharmacist triage services found that when 
clinical guidelines or protocols were utilized, pharmacist 
accuracy of assessment ranged between 70% and 98%, 
and when no guideline was used, correct diagnosis became 
more likely as the number of questions increased.22 An 
evaluation of an Australian pharmacy-based COPD 
screening program, during which pharmacists received 
accredited training and equipment to provide lung function 
tests found that the service was feasible, and similar pro-
grams have potential and may improve identification of 
undiagnosed COPD cases.29
The literature confirms many of the barriers to provid-
ing the level of care required for EPS that arose from this 
study, including lack of time, poor support from other 
pharmacy staff or employers, lack of training for pharmacy 
staff, little or no remuneration for services, staff shortages, 
poor support from other health professionals, and low 
patient engagement or awareness of services.19,30,31 
These issues could be addressed with the provision of 
training and education, staff support, and effective adver-
tising and promotion of services.30 In order to allow phar-
macists to provide effective and successful delivery of 
EPS, recommendations include the implementation of evi-
dence-based guidelines or protocols to assist with assess-
ment and diagnosis; thorough documentation and 
integration of care via collaboration with GPs and other 
health services, referrals and follow-up; the availability of 
a consult room to ensure patient privacy and confidenti-
ality; patient consultation with pharmacists rather than 
other pharmacy support staff; and greater public awareness 
of pharmacy services are essential.22 Furthermore, govern-
ance and drive from the Australian professional pharmacy 
associations is essential for EPS to be successfully 
implemented.
Limitations
A limitation of the study is selection bias that might have 
occurred in that only rural pharmacists with knowledge of 
and an interest in EPS may have participated. Furthermore, 
the small sample size is a limitation, however the even 
distribution of participants across the MMM categories 
does provide perspectives from regional to very remote 
areas. The estimated number of registered pharmacists 
across regional to very remote (MM2-7) is approximately 
5500, which constitutes less than 25% of total pharmacists 
in Australia.32 Although the number of responses are low, 
and generalizability is impaired, as a pilot study in an area 
of very limited evidence there is value in understanding 
rural pharmacists’ perceptions of expanded practice. The 
authors are planning further exploration using qualitative 
methods to provide a deeper understanding of this impor-
tant topic.
Conclusion
The findings from this study have revealed that although 
pharmacists have knowledge of EPS there may be some 
confusion as to what constitutes an expanded service. This 
demonstrates a need for the pharmacy profession to provide 
clarity regarding the terms used, including “full scope of 
practice”, “enhanced practice” and “expanded practice”. 
Clear understanding of this is required for expanded services 
to be successfully implemented. This pilot study has also 
highlighted positive perceptions regarding a full scope of 
practice, however a change in pharmacy practice requires 
input from diverse pharmacy organizations and other health 
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service providers to support pharmacists through this pro-
cess. Findings suggest that rural Australian pharmacists value 
the concept of expanded services, and in some places already 
provide them. Particular interest in mental health services 
indicates the recognition of the burden of mental health in 
rural and remote practice and the motivation to improve 
current service delivery. Further exploration of rural pharma-
cists’ knowledge, attitudes, and practices of expanded ser-
vices is important to provide evidence to support the design 
and development of future expanded practice models.
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